NBC NewsVaccine trials show early promising results — but major challenges are aheadJul 21, 2020Denise ChowBy Denise Chowmore_vert
The ConversationWhy vaccines are less effective in the elderly, and what it means for COVID-19Jul 20, 2020Byram Wayne Bridle & Shayan SharifBy Byram Wayne Bridle & Shayan Sharifmore_vert
STATNew data offer glimpse of efficacy of Oxford-AstraZeneca Covid-19 vaccineJul 20, 2020Helen Branswell, Matthew Herper & Damian GardeBy Helen Branswell, Matthew Herper & Damian Gardemore_vert
The New York TimesSome Vaccine Makers Say They Plan to Profit From Coronavirus Vaccine (Published 2020)May 4, 2021Katherine J. WuBy Katherine J. Wumore_vert
FiercePharmaWhere do COVID-19 vaccine players stand on pricing? So far, it's no profit, slight profit or undecidedJul 21, 2020Eric SagonowskyBy Eric Sagonowskymore_vert
BloombergDouble-Shot Covid Vaccines Multiply Immunization ChallengesJul 20, 2020Robert Langreth, James Paton & Stephanie BakerBy Robert Langreth, James Paton & Stephanie Bakermore_vert
WIREDCovid-19 Vaccines With 'Minor Side Effects' Could Still Be Pretty BadJul 21, 2020Hilda BastianBy Hilda Bastianmore_vert
The ConversationOxford immunologist on coronavirus vaccine: our early results look highly promisingJul 20, 2020Rebecca AshfieldBy Rebecca Ashfieldmore_vert
The New York TimesOxford Covid Vaccine Among Those Developers Say Have Promising Initial ResultsAug 11, 2020David D. KirkpatrickBy David D. Kirkpatrickmore_vert